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ABSTRACT: Multipl.e myeloma (MM) and Waldenstr6m's macroglobulinemia-like lymphoma (MW) 
appear spontaneously in C57BL/KaLwRij mice at a frequency of 0.5% and 0.2%, respectively. They can 
readily be propagated by intravenous transfer of mainly bone marrow or spleen ceils into syngeneic 
recipients. Previous studies demonstrated that these mouse malignant monoclonal gammopathies 
(MMG) show clinical and biologic features that closely resemble those of the corresponding human dis- 
eases and thus could be used as experimental models. We report on cytogenetic analysis of two mouse 
MW and five MM in vivo cell lines of the 5TMM series propagated in syngeneic mice. These studies 
demonstrated clonal abnormalities in all cell lines, hyperdiploid karyotype in both MW and one MM 
lines, and hypotriploidy, hypertriploidy, or hypotetraploidy in the other lines. Structural abnormalities 
of chromosome 15 were observed in all MM lines. In the five MM lines, frequent rearrangements were 
also found for chromosome numbers 1, 2, 5, and 12. A single chromosomal bnormality, as found in 
induced mouse plasmacytomas nd resembling Burkitt lymphoma, was not found in mouse MM and 
MW. It was concluded that spontaneously originating C57BL MM of the 5T series is a better model for 
human MM than pristane-induced BALB/c or NZB plasmacytoma. 
INTRODUCTION 
Multiple myeloma (MM) and Waldenstr/Sm's macroglobu- 
linemia-like lymphoma (MW) appear spontaneously in
mice of the C57BL/KaLwRij strain at a frequency of about 
0.5% and 0.2%, respectively [1, 2]. Both these malignant 
monoclonal gammopathies (MMG) of the 5T series can 
readily be propagated by intravenous transfer of mainly 
bone marrow or spleen cells into recipients of the same 
strain. Until now, ten different ransplantable mouse 5T 
lines have been developed. They differ substantially from 
mouse plasmacytomas originating after pristane injection 
in BALB/c mice [3]: in the bone marrow involvement, 
including the bone disease, in the way of growth, homing, 
and some other biologic features [1, 2]. So far, they were 
found to resemble their corresponding human diseases 
and therefore will possibly be useful as an experimental 
model. 
In human MM a variety of chromosome abnormalities 
were found. Frequent features were trisomy 3, 5, 7, 9, 11, 
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15, and 21, manosomy 8 and 13, as well as structural 
abnormalities of chromosomes 1 and 14, and some not 
fully identified genetic markers [4-8]. In human MW 
hyperdiploidy with restricted numerical and structural 
abnormalities plus one or two markers was reported [9- 
11]. Induced mouse plasmacytomas showed most resem- 
blance to human Burkitt lymphoma [3]. In both latter con- 
ditions a specific reciprocal translocation i volving the 
MYC oncogene and the immunoglobulin heavy or light 
chain locus was ob-served. 
In the present study, we investigated whether chromo- 
some abnormalities occurred in the mouse 5T lines and, if 
so, whether the mouse MM and MW lines resembled 
human MM and MW or mouse plasmacytoma. Further, the 
karyotype of two different ransfer generations, i.e., 6 and 
26, of the mouse 5T2MM was investigated for similarity of 
markers. 
MATERIALS AND METHODS 
Mouse Model of MMG (5T Model) 
Spontaneously originating mouse multiple myeloma nd 
Waldenstr/Sm's macroglobulinemia-like lymphoma have 
been maintained and propagated by intravenous transfer 
of bone marrow or spleen cells in syngeneic recipients of 
the C57BL/KaLwRij strain [1, 2] (Table 1). 
For cytogenetic analysis, cells from 10 different 5T 
MMG lines of different in vivo generation umbers were 
injected into mice of the sex opposite to that of the mouse 
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Table 3 Modal karyotype of the mouse MMG cell l ine passaged in vivo 
Line No. of 
MM/MW Sex tumor cells Modal karyotype 
5T2 M 20 
5T7 M 5 
5T14 M 23 
5T30 F 2 
5T33 F 5 
5T10 M 9 
5T18 M 10 
62-65,<3n>°XX,-Y?,mar1,2q+,inv(2),-4,(-4),+4q~(x3),5q -, 5,7q*,(-8),-9,-11, 
12p+,14q-,rcp t(15;15){q+;q ),robt(5;]5),+18q ,19q+,+4-6 markers 
64-66,<3n>°XX,-Y?,der(2), + 6,-  7,- 17,- 19,+mar1[robt(1;7}],+mar2[rob t(12;7)], 
+mar3[tan t(18;9 or 10)],+2mar4[der(inv15?)]+mar512p+],+2 small ring (Y?) 
58-59,<3n>a,XX,--Y,+1,ins(2)(50%) or 2q (50%),-4,-5,5q-,-8,-12,-14,15q , 
+15q-,+16,+17,+ large mar [?t(12;6)],+very small marker 
(NB: some intercellular variation in number of copies of normal chromosomes) 
42-43,X,-X?,t(1;9),der(6),t(12;14),t(12;19),+ 13,+ der(151,+ 17,+ small marker 
76-79,<4n>~,XX,-X,-X,t(1;15),t(1;15},inv(5),inv(5),-8,- lO,-15,-17,+ 2 mar 
41-43,X,-Y?,+X,2q ,3q+,4q+,  5,(+ 5),der(15), +der(15),18q-,+ 19(50%),+mar(50%) 
(NB: 3q ÷ and 4q ® = der of t(3;4;15) with possibly partial trisomy 15) 
42-43,X,marY?,5q+,8q÷,18q-,19q÷,+der t(16?;X),+1 or 2 small markers 
a<3n>,<4n>, in angle brackets i the ploidy number, e.g., 3n, triploidy; 4n, tetraploidy. Numerical changes are given relative to a triploid or tetraploid 
karyotype, respectively. 
according to standard procedure. Chromosomes were 
identified using R-, Qo, and sometimes also G-bands and 
classified according to nomenclature for mouse chromo- 
somes [•3]. 
Figure 1 R-banded karyotype of one 5T10 MW metaphase con- 
taining 43 chromosomes. Arrowheads indicate markers. 
RESULTS 
Characteristic features of the 10 C57BL/KaLwRij MMG 
lines that were investigated are shown in Table 1. With the 
followed methodology more aggressive MM lines, espe- 
cially the fast-growing 5T2, 5T14, and 5T33MM lines, 
could be karyotyped more easily than the slow-growing 
ones (5T7, 5T21). A summary of cytogenetic data of the 
mouse MM and MW cell lines is given in Tables 2 and 3. 
Cytogenetic analysis of in vivo transferred lines proved to 
be possible but presented some limitations compared to a 
study of in vitro established lines. Major complications 
were the admixture of normal recipient cells which at the 
time constituted the majority of the metaphases (Table 2), 
the l imited number of metaphases, and the time (a few 
months) required to repeat an experiment. To obviate 
these difficulties the recipient mouse used was usual ly of 
the opposite sex as the mouse in which the primary tumor 
originated and in some cases different animals were inoc- 
ulated at the same time with the same pool of tumor cells. 
It is noticeable that bone marrow specimens howed 
better chromosome morphology but a lower percentage of 
tumor metaphases than spleen, which showed poor chro- 
mosome morphology but a higher percentage of tumor 
metaphases. Mesenteric lymph node samples (5T2, 5T10) 
showed almost exclusively tumor cells. Al l  metaphases 
from recipient origin showed a normal diploid karyotype 
(40, XX and 40, XY) with infrequent random loss of i or 2 
chromosomes; chromosome breaks and translocations 
were very exceptional. In three of the lines (5T13, 5T21, 
and 5T16) only the recipient's own cells were found. The 
mouse MMG cell l ines were characterized by aneuploidy 
and clonal abnormalities (Table 3), consistent in different 
animals injected with the same tumor lines, even after a 
number of in vivo transfers (5T2). Most of the tumor lines 
were of male origin, but they showed loss of Y chromo- 
somes and thus the discrimination between recipient and 
tumor metaphases based on sex chromosomes was less 
reliable than expected. 
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Figure 2 R-banded karyotype of one 5T2 MM metaphase con- 
taining 63 chromosomes. The majority of markers are indicated 
by arrowhead. There is no normal chromosome 4 but 3 copies of 
4q ÷, one with a break near the centromere; there is no normal 
chromosome 15; the 18q- arLd the 19q ÷ were not seen in this par- 
ticular cell. 
The two MW lines, 5T10 (Fig. 1) and 5T18, resembled 
each other somewhat cylogenetically. Hyperdiploidy with 
42-43 chromosomes, 18q-, numerical or structural abnor- 
malities of chromosome 5 and 19, plus one or two small 
markers were shared features of the two MW lines. In 
human MW, hyperdiploidy with restricted numerical and 
structural abnormalities plus one or two markers have 
been reported [9-11], observations similar to the findings 
in the 5T10 and 5T18 MW lines. 
In the 5T MM lines a variety of chromosomal bnormal- 
ities was found (Table 3). A hyperdiploid number of chro- 
mosomes was detected in 5T30. Here, only two cells could 
be analyzed. Hypotriplo:[dy with 58-59 chromosomes was 
found for the 5T14 MM cell line. In two cases, 5T2 (Fig. 2) 
and 5T7, hypertriploidy with 62-66 chromosomes was 
detected. Hypotetraploidy with 76-79 chromosomes was 
found for the 5T33 cell line. In general, male mouse MM 
tumor cells tended to lose the Y-chromosome. Structural 
changes of chromosomes were variable. Chromosome 15, 
where the MYC oncogene was mapped in the 15D2/D3 
region [14], was rearranged in all five lines (Fig. 3). These 
rearrangements resulted in overrepresentation of (part of) 
chromosome 15 withoul: specificity, apparently, and as far 
Figure 3 Partial karyotype (R-bands) of the 5T cell lines show- 
ing rearrangements of chromosome 15. 5T2, rcp t(15;15)(?B;?D3) 
and Rb(5;15); 5T7, two copies of mar 4 interpreted as inv (15), 
one copy of mar 5 interpreted as der (2;5) and three copies of 
chromosome 15; 5T10, chromosome pairs 3 and 4 showing t(3;4;15) 
(G;E;?A) and two normal chromosome 15; 5T14, two normal 15 
and two del(15)(D?3); 5T30, two normal 15 and a der (15); 5T33, 
two normal 1, two der(15;1)(E;C), and three normal 15. 
as can be determined at the banding level. Further, fre- 
quent alterations were also found for chromosome num- 
bers 1, 2, 5, and 12, in addition to the numerous numerical 
changes. 
Since no common cytogenetic characteristics were detec- 
ted among the MM lines, the known biologic variations of 
the MM lines could not be related to chromosome abnor- 
malities. Thus, the 5T7 line that clinically behaves like a 
smoldering MM and 5T14 line with both lytic and osteo- 
sclerotic bone lesions could not be distinguished cytoge- 
netically from the other MM lines. The 5T2 MM cell l ine 
was karyotyped at transfer generations 6 and 26. The latter 
showed cells of less quality than the former, a slight 
decrease in modal chromosome number but persistence of
the same characteristic markers. 
DISCUSSION 
The chromosome abnormalities found in the mouse MM 
lines are similar to those in human MM. Frequent features 
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in human MM were trisomy 3, 5, 7, 9, 11, 15, and 21, 
monosomy 8 and 13, several structural abnormal chromo- 
somes, and some not fully identified markers [4-8]. 
Characteristic translocations a are known for Burkitt lym- 
phoma [15] in humans and in plasmacytoma in mouse [3] 
were not observed. Mouse plasmacytomas, induced by 
pristane injection of BALB/c or NZB mice, consistently 
contain one of two alternative translocations, the typical 
rcpt (12;15} or the variant rcp t(6;15) (3, 14). The break- 
point on chromosome 15 in plasmacytomas was found to 
map in the D2/D3 region where the MYC oncogene is 
located [14]. Using Southern blot technique DNA rear- 
rangement of the MYC oncogene was consistently detected 
in mouse plasmacytomas [14]. In the 5T series, chromo- 
some 15 was involved in chromosomal berrations in all 
MM lines. However, here no DNA rearrangement of the 
MYC oncogene was found by Southern blot analysis of 
spleen cells from all 5T MM-bearing mice investigated [17, 
18]. In 5T2 bone marrow and in 5T2 and 5T14 ascitic cells 
rearrangement of he MYC oncogene was detected [17, 18]. 
In human MM, rearrangement of the MYC oncogene was 
found only in exceptional cases, such as in a very progres- 
sive IgA-MM involving pleural tissue and in a case of 
plasma cell leukemia [19-21]. These data of mouse and 
human MM can be interpreted as indicating that MYC 
rearrangement i  MM can take place, possibly as a late 
event in the progression of this malignancy. Thus, MYC 
rearrangement is not a consistent feature of mouse and 
human MM, in contrast o mouse plasmacytoma. On the 
basis of these great differences of cytogenetic and molecu- 
lar genetic data between C57BL MM and BALB/c plasma- 
cytoma, we conclude that spontaneously arising C57BL 
MM and pristane-induced plasmacytoma re different 
tumors. Comparing both biologic [16] and cytogenetic data 
of human MM with C57BL MM and BALB/c plasmacy- 
toma we further conclude that C57BL MM of the 5T series 
is an appropriate model for human MM, in contrast o 
BALB/c plasmacytoma. 
In this study we could show major karyotypic hanges 
in mouse MW and MM lines of the 5T series. These cyto- 
genetic abnormalities were clonal and relatively stable 
characteristics of each individual lines. This indicates 
that, in the future, molecular genetics and molecular cyto- 
genetic technical approaches can be applied to investigate 
these lines for specific gene rearrangements and alter- 
ations of gene expression. In conclusion, our data confirm 
other observations on the close resemblance of the cytoge- 
netic characteristics of human MM and MW on the one 
hand, and mouse MM and MW 5T lines on the other. This 
suggests that these MMG of the 5T series may offer a good 
experimental model for studies on several aspects of MM 
and MW. 
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